We performed a rigorous comparison of the in vivo antitumor activity of candidate CPR/CART in two orthotopic models of GBM and found that CPR with 41BB costimulation augmented the efficacy of first-generation HER2-CART (CARζ/CPR41BB) over the second-generation counterparts. Here, ERBB2 is linked to glioblastoma.